Edwards Lifesciences Corp·4

May 11, 9:32 PM ET

Zovighian Bernard J 4

Research Summary

AI-generated summary

Updated

Edwards (EW) CEO Bernard Zovighian Receives Stock Awards

What Happened
Bernard J. Zovighian, CEO and Director of Edwards Lifesciences (EW), received new equity awards on May 7, 2026 under the company's Long‑Term Stock Incentive Program. The filing shows awards totaling 332,900 shares (includes time‑based and performance/derivative awards). To cover tax liabilities associated with these awards, 9,551 shares were surrendered (withheld) on May 7–8 for a total cash value of $792,268. Separately, gift/transfer transactions totaling about 9,711 shares occurred on May 8 and May 11. These transactions are award grants and transfers, not open‑market purchases or sales.

Key Details

  • Primary award date: May 7, 2026 — new awards reported totaling 332,900 shares (includes derivative/performance awards).
  • Tax withholding: 4,153 shares surrendered at $83.20 each = $345,530 (May 7); 5,398 shares surrendered at $82.76 each = $446,738 (May 8). Total withheld = 9,551 shares / $792,268.
  • Gifts/transfers: 4,222 shares (May 8) and 5,489 shares (May 11) — total ~9,711 shares reported as gifts/transfers.
  • Vesting and award types (per filing footnotes):
    • Time‑based RSUs: granted May 7; vest in four equal annual installments starting one year after grant (Footnote F1).
    • Stock options: granted May 7; vest monthly over ~36 months beginning one month after grant (Footnote F2).
    • Performance RSUs (Target Award): granted May 7; target amount vests on May 7, 2029 subject to performance (0%–200%) (Footnote F3).
  • Shares owned after these transactions: not disclosed in this Form 4 (filing notes it reflects changes only).
  • Filing timeliness: Reported May 11, 2026 for May 7 transactions — filed within the required 2 business days.

Context
These entries primarily reflect equity compensation (awards and options) and routine tax withholding (code F) rather than an open‑market sale or purchase. Gift/transfer entries (code G) are transfers and do not necessarily indicate the insider’s view of the company’s stock. The performance RSUs are subject to future vesting and may pay out between 0%–200% of the target depending on results through 2029.